Psychological impact of prostate biopsy: Physical symptoms, anxiety, and depression

Journal of Clinical Oncology

Volumn 31, Issue 33, 2013, Pages 4235-4241

  Wade, Julia ^a   Rosario, Derek J ^b   Macefield, Rhiannon C ^a   Avery, Kerry N L ^a   Salter, C Elizabeth ^a   Goodwin, M Louise ^b   Blazeby, Jane M ^a   Lane, J Athene ^a   Metcalfe, Chris ^a   Neal, David E ^c   Hamdy, Freddie C ^d   Donovan, Jenny L ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANXIETY; ARTICLE; COHORT ANALYSIS; DEPRESSION; FEVER; FOLLOW UP; HEMATURIA; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PAIN; PHYSICAL DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE BIOPSY; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; RECTUM HEMORRHAGE; AGED; BIOPSY; MASS SCREENING; MENTAL STRESS; MIDDLE AGED; PATHOLOGY; PROSTATE; PROSTATE TUMOR; PSYCHOLOGICAL RATING SCALE; STATISTICAL MODEL; TIME; PROSTATIC NEOPLASMS; PSYCHOLOGY;

AGED; ANXIETY; BIOPSY; DEPRESSION; HUMANS; LINEAR MODELS; MALE; MASS SCREENING; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATE; PROSTATIC NEOPLASMS; PSYCHIATRIC STATUS RATING SCALES; QUESTIONNAIRES; STRESS, PSYCHOLOGICAL; TIME FACTORS;

EID: 84892884313     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2012.45.4801     Document Type: Article

References (25)

1. American Cancer Society: Cancer Facts and Figures 2011. Atlanta, GA, American Cancer Society. http:// www.cancer.org/acs/groups/content/@epidemiology surveilance/documents/document/acspc-029771.pdf
2. Collin SM, Martin RM, Metcalfe C, et al: Prostate-cancer mortality in the USA and UK in 1975-2004: an ecological study. Lancet Oncol 9:445- 452, 2008
3. Welch HG, Fisher ES, Gottlieb DJ, et al: Detection of prostate cancer via biopsy in the Medicare-SEER population during the PSA era. J Natl Cancer Inst 99:1395-1400, 2007 (Pubitemid 351767186)
4. Donovan J, Hamdy F, Neal D, et al: Prostate Testing for Cancer and Treatment (ProtecT) feasibility study. Health Technol Assess 7:1-88, 2003
5. Litwin MS, Saigal CS: Prostate cancer, in Urologic Disease in America. National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Public Health Service, United States Department of Health and Human Services. National Institutes of Health Publication No. 07-5512. Washington, DC, United States Government Publishing Office, 2007, p 76
6. Schröder FH, Hugosson J, Roobol MJ, et al: Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 360:1320- 1328, 2009
7. Andriole GL, Crawford ED, Grubb RL 3rd, et al: Mortality results from a randomized prostatecancer screening trial. N Engl J Med 360:1310- 1319, 2009
8. Screening for prostate cancer: US Preventive Services Task Force statement. Ann Intern Med 157:1-44, 2012
9. Chou R, Croswell JM, Dana T, et al: Screening for prostate cancer: A review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 155:762-771, 2011
10. Loeb S, Carter HB, Berndt SI, et al: Complications after prostate biopsy: Data from SEERMedicare. J Urol 186:1830-1834, 2011
11. Nam RK, Saskin R, Lee Y, et al: Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy. J Urol 183:963-969, 2010
12. Loeb S, van den Heuvel S, Zhu X, et al: Infectious complication and hospital admissions after prostate biopsy in a European randomized trial. Eur Urol 61:1110-1114, 2012
13. Rosario DJ, Lane JA, Metcalfe C, et al: Shortterm outcomes of prostate biopsy in men tested for cancer by PSA: A prospective evaluation within the ProtecT study. BMJ 344:d7894, 2012
14. Lane JA, Hamdy FC, Martin RM, et al: Latest results from the UK trials evaluating prostate cancer screening and treatment: The CAP and ProtecT studies. Eur J Cancer 46:3095-3101, 2010
15. Zigmond AS, Snaith RP: The Hospital Anxiety and Depression Scale. Acta Psychiat Scand 67:361- 370, 1983 (Pubitemid 13098606)
16. Vordermaier A, Linden W, Siu C: Screening for emotional distress in cancer patients: A systematic review of assessment instruments. J Natl Cancer Inst 101:1464-1488, 2009
17. Lampic C, Thurfjell E, Bergh J, et al: Short- and long-term anxiety and depression in women recalled after breast cancer screening. Eur J Cancer 37:463- 469, 2001 (Pubitemid 32232110)
18. Crawford JR, Henry JD, Crombie C, et al: Normative data for the HADS from a large nonclinical sample. Br J Clin Psychol 40:429-434, 2001 (Pubitemid 33080898)
19. Avery KN, Blazeby JM, Lane JA, et al: Decision-making about PSA testing and prostate biopsies: A qualitative study embedded in a primary care randomized trial. Eur Urol 53:1186- 1193, 2008 (Pubitemid 351615449)
20. Rocco B, de Cobelli O, Leon ME, et al: Sensitivity and detection rate of a 12-core trans-perineal prostate biopsy: Preliminary report. Eur Urol 49:827- 833, 2006
21. Pinsky PF, Crawford ED, Kramer BS, et al: Repeat prostate biopsy in the prostate, lung, colorectal and ovarian cancer screening trial. BJU International 99:775-779, 2007 (Pubitemid 46439580)
22. Essink-Bot ML, de Koning HJ, Nijs HG, et al: Short-term effects of population-based screening for prostate cancer on health-related quality of life. J Natl Cancer Inst 90:925-931, 1998 (Pubitemid 28304162)
23. Zisman A, Leibovici D, Kleinmann J, et al: The impact of prostate biopsy on patient well-being: A prospective study of pain, anxiety and erectile dysfunction. J Urol 165:445-454, 2001 (Pubitemid 32060434)
24. Fowler FJ Jr, Barry MJ, Walker-Corkery B, et al: The impact of a suspicious prostate biopsy on patients' psychological, socio-behavioral, and medical care outcomes. J Gen Intern Med 21:715-721, 2006 (Pubitemid 43973556)
25. Macefield RC, Metcalfe C, Lane JA, et al: Impact of prostate cancer testing: An evaluation of the emotional consequences of a negative biopsy result. Br J Cancer 102:1335-1340, 2010